Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 83 of 291 for:    Sodium Fluoride OR Duraphat

Comparing Mouth Rinses in Regard to Streptococcus Mutans Reduction

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02598778
Recruitment Status : Unknown
Verified November 2015 by Montefiore Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : November 6, 2015
Last Update Posted : November 6, 2015
Sponsor:
Information provided by (Responsible Party):
Montefiore Medical Center

Brief Summary:
This study compares four mouth rinses in their regard to reducing Streptococcus Mutans after use. The four mouth that will be compared are chlorhexidine gluconate (.12%), sodium fluoride (.05%), coconut oil, and deionized water.

Condition or disease Intervention/treatment Phase
Oral Salivary Streptococcus Mutans Counts Drug: Chlorhexidine gluconate (.12%) Drug: Sodium Fluoride (.05%) Other: Coconut Oil Other: Deionized water Not Applicable

Detailed Description:
The study is a randomized controlled clinical trial, unblinded. Once consent and assent have been obtained, the participant will be randomly assigned to one of the four mouth rinses being studied. A pre rinse stimulated salivary sample will be taken in which about 3cm of a sterile tongue depressor is introduced into the mouth and turned around 10 times to contaminate it with saliva. Each side of the spatula was then pressed against a petri dish containing Mitis-salivarius agar. The patient will then rinse 10 ml of the assigned rinse for a timed 30 seconds, expectorate, and then a post stimulated salivary sample will be taken similarly to the pre rinse sample. The samples will be transported to a lab for incubation and quantitative analysis of Streptococcus Mutans.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: Comparing Chlorhexidine Gluconate, Sodium Fluoride, Coconut Oil and Water Mouth Rinses in Regard to Streptococcus Mutan Reduction
Study Start Date : November 2015
Estimated Primary Completion Date : February 2016
Estimated Study Completion Date : May 2016


Arm Intervention/treatment
Active Comparator: Chlorhexidine gluconate (.12%)
An oral rinse given to pediatric patients in routine practice within the standard of care.
Drug: Chlorhexidine gluconate (.12%)
30 second oral rinse of 10mL of solution
Other Name: Peridex

Active Comparator: Sodium fluoride oral rinse (.05%)
An oral rinse given to pediatric patients in routine practice within the standard of care.
Drug: Sodium Fluoride (.05%)
30 second oral rinse of 10mL of solution
Other Name: ACT mouthrinse

Active Comparator: Coconut oil
A food product. In previous studies it has shown positive effects on the reduction of oral plaque and gingivitis as an oral rinse.
Other: Coconut Oil
30 second oral rinse of 10mL of solution

Placebo Comparator: Deionized water
Water that has had the majority of its ions removed.
Other: Deionized water
30 second oral rinse of 10mL of solution




Primary Outcome Measures :
  1. Quantitative analysis of change in Salivary Streptococcus Mutans after 30 second oral rinse [ Time Frame: 30 seconds ]
    A quantitative analysis of salivary Streptococcus Mutans will be done pre and post 30 second oral rinse



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   6 Years to 12 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Patients presenting to the dental clinic for routine dental treatment (including recall exams, new patient exams, and operative appointments) who are ASA class I or II, cooperative patients classified as 3 or 4 according to the Frankl Behavioral Rating Scale,
  • No known allergies or sensitivities to products or ingredients being tested

Exclusion Criteria:

  • ASA III or above
  • Known allergies or sensitivities to any of the mouth rinses or any of the ingredients in the mouth rinses to be tested
  • Non English speaking parent or participant
  • Patient presenting to the clinic as a walk in or emergency appointment
  • Patient experiencing any pain or sensitivity
  • consuming any beverage or food or performing oral hygiene practices such as brushing or flossing, within 1 hour prior to trial participation
  • No use of a mouth rinse in the last 24 hours
  • Precooperative or uncooperative behavior or behavior classified as 1 or 2 according to the Frankl Behavioral Rating Scale

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02598778


Contacts
Layout table for location contacts
Contact: Jessica Mattern, DDS 4807940302 jmattern@montefiore.org
Contact: Janna Danbe, DMD jkohout@montefiore.org

Locations
Layout table for location information
United States, New York
Montefiore Medical Center Not yet recruiting
Bronx, New York, United States, 10467
Contact: Nuntiya Kakanantadilok, DMD    718-920-1740 ext 2135      
Contact: Jessica Mattern, DDS    4807940302    jmattern@montefiore.org   
Sponsors and Collaborators
Montefiore Medical Center
Investigators
Layout table for investigator information
Principal Investigator: Nuntiya Kakanantadilok, DMD Montefiore Medical Center

Layout table for additonal information
Responsible Party: Montefiore Medical Center
ClinicalTrials.gov Identifier: NCT02598778     History of Changes
Other Study ID Numbers: 2015-5583
First Posted: November 6, 2015    Key Record Dates
Last Update Posted: November 6, 2015
Last Verified: November 2015
Additional relevant MeSH terms:
Layout table for MeSH terms
Listerine
Fluorides
Sodium Fluoride
Chlorhexidine
Chlorhexidine gluconate
Cariostatic Agents
Protective Agents
Physiological Effects of Drugs
Anti-Infective Agents, Local
Anti-Infective Agents
Disinfectants
Dermatologic Agents